MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 183 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,858,000 | +12.2% | 217,950 | +22.3% | 0.00% | 0.0% |
| Q3 2016 | $3,439,000 | -0.9% | 178,269 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $3,471,000 | +3.0% | 178,021 | +8.9% | 0.00% | 0.0% |
| Q1 2016 | $3,369,000 | +1.4% | 163,473 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $3,321,000 | +21.0% | 161,855 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $2,744,000 | -9.0% | 160,470 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $3,016,000 | +14.5% | 161,787 | +17.2% | 0.00% | +33.3% |
| Q1 2015 | $2,633,000 | +17.7% | 138,020 | +1.6% | 0.00% | 0.0% |
| Q4 2014 | $2,237,000 | -7.4% | 135,883 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $2,415,000 | -14.4% | 136,536 | -0.1% | 0.00% | -25.0% |
| Q2 2014 | $2,820,000 | -5.9% | 136,646 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $2,998,000 | -17.4% | 137,577 | +0.6% | 0.00% | -20.0% |
| Q4 2013 | $3,628,000 | +10.8% | 136,754 | -1.3% | 0.01% | 0.0% |
| Q3 2013 | $3,274,000 | +15.4% | 138,566 | +5.0% | 0.01% | 0.0% |
| Q2 2013 | $2,837,000 | – | 131,965 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |